These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12479880)

  • 1. Effects of insulin on platelet and leukocyte activity in whole blood.
    Hu H; Hjemdahl P; Li N
    Thromb Res; 2002 Sep; 107(5):209-15. PubMed ID: 12479880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast medium attenuates platelet activation and platelet-leukocyte cross-talk.
    Ji Q; Ghaly M; Hjemdahl P; Tornvall P; Li N
    Thromb Haemost; 2005 May; 93(5):922-6. PubMed ID: 15886810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin, but not proinsulin C-peptide, enhances platelet fibrinogen binding in vitro in Type 1 diabetes mellitus patients and healthy subjects.
    Hu H; Li N; Ekberg K; Johansson BL; Hjemdahl P
    Thromb Res; 2002 Apr; 106(2):91-5. PubMed ID: 12182905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for prothrombotic effects of exercise and limited protection by aspirin.
    Li N; Wallén NH; Hjemdahl P
    Circulation; 1999 Sep; 100(13):1374-9. PubMed ID: 10500036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy.
    Hu H; Li N; Yngen M; Ostenson CG; Wallén NH; Hjemdahl P
    J Thromb Haemost; 2004 Jan; 2(1):58-64. PubMed ID: 14717967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood.
    Maugeri N; Di Fabio G; Barbanti M; de Gaetano G; Donati MB; Cerletti C
    Thromb Haemost; 2007 Jun; 97(6):965-73. PubMed ID: 17549299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-leukocyte cross talk in whole blood.
    Li N; Hu H; Lindqvist M; Wikström-Jonsson E; Goodall AH; Hjemdahl P
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2702-8. PubMed ID: 11116075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry.
    Li N; Hu H; Hjemdahl P
    Thromb Res; 2003; 111(3):165-70. PubMed ID: 14678815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of sevoflurane and desflurane in vitro on platelet-leukocyte adhesion in whole blood.
    Horn NA; de Rossi L; Robitzsch T; Hecker KE; Hutschenreuter G; Rossaint R
    Anaesthesia; 2003 Apr; 58(4):312-9. PubMed ID: 12648111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty.
    Mickelson JK; Ali MN; Kleiman NS; Lakkis NM; Chow TW; Hughes BJ; Smith CW
    J Am Coll Cardiol; 1999 Jan; 33(1):97-106. PubMed ID: 9935015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood.
    Izzi B; Pampuch A; Costanzo S; Vohnout B; Iacoviello L; Cerletti C; de Gaetano G
    Thromb Haemost; 2007 Dec; 98(6):1276-84. PubMed ID: 18064325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glucose levels enhance platelet activation: involvement of multiple mechanisms.
    Sudic D; Razmara M; Forslund M; Ji Q; Hjemdahl P; Li N
    Br J Haematol; 2006 May; 133(3):315-22. PubMed ID: 16643434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase III inhibition affects platelet-monocyte aggregate formation depending on the axis of stimulation.
    Horn NA; Anastase DM; Hecker KE; Baumert JH; Scheffer GJ; Rossaint R
    J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):162-6. PubMed ID: 16616654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of platelet-activating factor in aggregation of leukocytes and platelets in cerebral ischemia.
    Uchiyama S; Yamazaki M; Maruyama S
    Lipids; 1991 Dec; 26(12):1247-9. PubMed ID: 1819711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced platelet and leucocyte activation is not enhanced in well-controlled Type 1 diabetes, despite increased activity at rest.
    Hu H; Johansson BL; Hjemdahl P; Li N
    Diabetologia; 2004 May; 47(5):853-9. PubMed ID: 15095037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
    Hammerschmidt DE; Kotasek D; McCarthy T; Huh PW; Freyburger G; Vercellotti GM
    J Lab Clin Med; 1988 Aug; 112(2):254-63. PubMed ID: 2840477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epinephrine enhances platelet-neutrophil adhesion in whole blood in vitro.
    Horn NA; Anastase DM; Hecker KE; Baumert JH; Robitzsch T; Rossaint R
    Anesth Analg; 2005 Feb; 100(2):520-526. PubMed ID: 15673886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of halothane and isoflurane on binding of ADP- and TRAP-6- activated platelets to leukocytes in Whole blood.
    de Rossi LW; Horn NA; Hecker KE; Robitzsch T; Hutschenreuter G; Rossaint R
    Anesthesiology; 2002 Jan; 96(1):117-24. PubMed ID: 11753011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation.
    Ruef J; Kuehnl P; Meinertz T; Merten M
    Platelets; 2008 Aug; 19(5):359-64. PubMed ID: 18791942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin enhances platelet activation in vitro.
    Yngen M; Li N; Hjemdahl P; Wallén NH
    Thromb Res; 2001 Oct; 104(2):85-91. PubMed ID: 11672752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.